Nureca Enterprise Value (EV)

Nureca Ltd Enterprise Value

The Nureca Ltd Enterprise Value is a key financial metric used by investors to evaluate Nureca Ltd's valuation, profitability, and overall financial performance. Tracking the Nureca Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Nureca Ltd (NSE: NURECA, BSE: 543264) is currently trading at ₹295.20, with a market capitalization of ₹2.8B. As a leading company in the Health technology sector and Medical specialties industry, monitoring the Nureca Ltd Enterprise Value is essential for fundamental analysis.

Nureca Ltd Enterprise Value Current Value

The current Nureca Ltd Enterprise Value stands at 868.89M.

The Nureca Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Nureca Ltd Enterprise Value Historical Trend

The Nureca Ltd Enterprise Value has shown the following historical trend:

• 2024: 868.89M
• 2023: 1.14B
• 2022: 1.72B
• 2021: 12.49B
• 2020: 3.27B

The decline in Nureca Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Nureca Ltd Enterprise Value Indicates for Investors

The Nureca Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Nureca Ltd.

Nureca Ltd Enterprise Value Analysis Summary

The Nureca Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Nureca Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Nureca Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.